KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 77 filers reported holding KEZAR LIFE SCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $988 | +35.5% | 831,693 | +179.2% | 0.00% | +33.3% |
| Q2 2023 | $729 | +1520.0% | 297,933 | +1952.4% | 0.00% | – |
| Q1 2023 | $45 | -100.0% | 14,516 | -82.8% | 0.00% | -100.0% |
| Q2 2022 | $700,000 | -83.8% | 84,584 | -67.3% | 0.00% | -75.0% |
| Q4 2021 | $4,328,000 | +46.0% | 258,946 | -24.6% | 0.02% | +45.5% |
| Q3 2021 | $2,965,000 | +62.3% | 343,400 | +2.0% | 0.01% | +57.1% |
| Q2 2021 | $1,827,000 | -8.9% | 336,563 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $2,006,000 | +17.6% | 336,563 | +3.0% | 0.01% | +14.3% |
| Q4 2020 | $1,706,000 | +21.3% | 326,793 | +12.4% | 0.01% | +16.7% |
| Q3 2020 | $1,407,000 | +25.1% | 290,870 | +33.8% | 0.01% | +20.0% |
| Q2 2020 | $1,125,000 | +62.3% | 217,395 | +36.8% | 0.01% | +25.0% |
| Q1 2020 | $693,000 | +42.0% | 158,885 | +30.6% | 0.00% | +100.0% |
| Q4 2019 | $488,000 | +180.5% | 121,670 | +129.7% | 0.00% | +100.0% |
| Q3 2019 | $174,000 | +62.6% | 52,974 | +283.0% | 0.00% | 0.0% |
| Q2 2019 | $107,000 | – | 13,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
| Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
| Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
| Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
| CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
| Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
| Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |